Home Cart Sign in  
Chemical Structure| 1956426-56-4 Chemical Structure| 1956426-56-4

Structure of KN-93 HCl
CAS No.: 1956426-56-4

Chemical Structure| 1956426-56-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KN-93 hydrochloride is a cell-permeable, reversible, and competitive inhibitor of calmodulin-dependent kinase type II (CaMKII) with a Ki of 370 nM.

Synonyms: KN-93 (hydrochloride); KN-93 hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KN-93 HCl

CAS No. :1956426-56-4
Formula : C26H30Cl2N2O4S
M.W : 537.50
SMILES Code : CN(CC1=CC=CC=C1N(CCO)S(=O)(C2=CC=C(C=C2)OC)=O)C/C=C/C3=CC=C(C=C3)Cl.Cl
Synonyms :
KN-93 (hydrochloride); KN-93 hydrochloride
MDL No. :MFCD27992054
InChI Key :ATHMCQDBXQEIOK-IPZCTEOASA-N
Pubchem ID :73425340

Safety of KN-93 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
rabbit ventricular myocytes 1 μmol/l suppressed hypokalemia-induced EADs PMC4618042
adult mouse ventricular myocytes 1 μmol/L 30 minutes KN-93 completely prevented the high glucose-induced ROS generation PMC7210078
μMG1 cells 5.22 ± 0.3 µM 72 hours KN93 inhibits the TRPM1-driven Ca2+/CaMKIIδ/AKT pathway, thereby suppressing tumor-promoting activity PMC9811324
HEK293T cells 20 µM 24 hours To investigate the effect of KN-93 on Kv4.1 phosphorylation, results showed that KN-93 significantly reduced the phosphorylation level of Kv4.1. PMC8333054

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Liver metastasis model Intraperitoneal injection 25 mg/kg, 50 mg/kg, 100 mg/kg Twice daily for 5 days The combination therapy of KN93 and gemcitabine was more effective than single drug therapy, significantly inhibiting tumor growth and prolonging the survival time of nude mice. PMC10920868
rabbit hypokalemia model perfusion 20 mg/kg Once daily for 2-3 weeks prevented hypokalemia-induced VT/VF PMC4618042
Zebrafish Zebrafish heart model Intraperitoneal injection 0.1ml/10g Twice daily for one week KN-93 protected zebrafish hearts from H2O2-induced disruption of electrical gradients, and the protection was complete if administered prior to oxidative stress exposure. PMC8262641
mice CA11 human acral melanoma subcutaneous xenograft model intraperitoneal injection 1 μmol/l 30 minutes KN93 significantly suppressed the growth of CA11 xenograft tumors and reduced phosphorylation levels of CaMKII and AKT PMC9811324

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.30mL

1.86mL

0.93mL

18.60mL

3.72mL

1.86mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories